Zejula
Drug timelines are a Plus or Pro feature.
28 regulatory and trial events tracked for Zejula, covering 2020-06-11 to 2026-06-10. Get the full timeline:
Most recent: EMA Authorised: Zejula (niraparib (tosilate monohydrate)) — GlaxoSmithKline Trading Services Limited